Application of a clinical decision support tool for predicting outcomes with vedolizumab therapy in patients with inflammatory bowel disease: A KASID multicenter study

被引：0
|
作者：
Kim, K. [1 ]
Hong, S. W. [1 ]
Park, J. H. [1 ]
Hwang, S. W. [1 ,2 ]
Park, S. H. [1 ,2 ]
Yang, D. H. [1 ]
Byeon, J. S. [1 ]
Myung, S. J. [1 ]
Yang, S. K. [1 ,2 ]
Yoo, J. H. [3 ]
Boo, S. J. [4 ]
Kim, E. S. [5 ]
Lee, J. [6 ]
Kim, K. O. [7 ]
Ye, B. D. [1 ,2 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Asan Med Ctr, Ctr Inflammatory Bowel Dis, Seoul, South Korea
[3] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Sch Med, Seongnam, South Korea
[4] Jeju Natl Univ, Dept Internal Med, Sch Med, Jeju, South Korea
[5] Korea Univ, Anam Hosp, Dept Gastroenterol, Seoul, South Korea
[6] Chosun Univ, Dept Internal Med, Coll Med, Gwangju, South Korea
[7] Yeungnam Univ, Dept Internal Med, Coll Med, Daegu, South Korea
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P560
引用
收藏
页码：I503 / I504
页数：2
相关论文
共 50 条
  • [41] Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab
    Allegretti, Jessica R.
    Barnes, Edward L.
    Stevens, Betsey
    Storm, Margaret
    Ananthakrishnan, Ashwin
    Yajnik, Vijay
    Korzenik, Joshua
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (06) : 1590 - 1596
  • [42] CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND DOCUMENTED CANNABIS USE DISORDERS: A MULTICENTER NETWORK STUDY
    Tanner, Samuel
    Perez, Jaime
    Martin, Scott A.
    Mansoor, Emad
    Katz, Jeffry
    Cominelli, Fabio
    Nguyen, Vu Q.
    GASTROENTEROLOGY, 2023, 164 (06) : S458 - S458
  • [43] Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
    Johnson, Elizabeth
    Eldasher, Lobna
    Dulai, Parambir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S858 - S858
  • [44] Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease
    Dulai, Parambir S.
    Johnson, Elizabeth
    Cox, Kenny
    Eldasher, Lobna M.
    Theriault, Nicolette
    INFLAMMATORY BOWEL DISEASES, 2024,
  • [45] Postoperative outcomes of surgical delay in inflammatory bowel disease patients: a multicenter cohort study
    de Bock, Ellen
    Herman, Eline S.
    Meij, Vincent
    Burghgraef, Thijs A.
    Oldenburg, Bas
    Verheijen, Paul M.
    Pronk, Apollo
    Filipe, Mando D.
    Vriens, Menno R.
    Richir, Milan C.
    UPDATES IN SURGERY, 2024, 76 (04) : 1271 - 1277
  • [46] Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study
    Moens, Annick
    van der Woude, C. Janneke
    Julsgaard, Mette
    Humblet, Evelien
    Sheridan, Juliette
    Baumgart, Daniel C.
    Gilletta De Saint-Joseph, Cyrielle
    Nancey, Stephane
    Rahier, Jean-Francois
    Bossuyt, Peter
    Cremer, Anneline
    Dewit, Sophie
    Eriksson, Carl
    Hoentjen, Frank
    Krause, Thomas
    Louis, Edouard
    Macken, Elisabeth
    Milenkovic, Zoran
    Nijs, Jochen
    Posen, Annelies
    Van Hootegem, Anneleen
    Van Moerkercke, Wouter
    Vermeire, Severine
    Bar-Gil Shitrit, Ariella
    Ferrante, Marc
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (01) : 129 - 138
  • [47] Inflammatory Bowel Disease Population Analyzer Tool for Health Systems (IBD PATH): a case study risk stratifying patients with inflammatory bowel disease for clinical outcomes
    Deering, Kathleen L.
    Patel, Aarti A.
    Babin, Sheena
    Capelouto, Joseph
    Kabagambe, Edmond K.
    Shah, Shamita B.
    JOURNAL OF HOSPITAL MANAGEMENT AND HEALTH POLICY, 2024, 8
  • [48] The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study
    Ramos, Guilherme Piovezani
    Dimopoulos, Christina
    McDonald, Nicholas M.
    Janssens, Laurens P.
    Hung, Kenneth W.
    Proctor, Deborah
    Ruggiero, Elizabeth
    Kane, Sunanda
    Bruining, David H.
    Faubion, William A.
    Raffals, Laura E.
    Loftus, Edward V., Jr.
    Al-Bawardy, Badr
    JOURNAL OF ANIMAL SCIENCE, 2022, 100 (09) : 1270 - 1276
  • [49] The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study
    Ramos, Guilherme Piovezani
    Dimopoulos, Christina
    McDonald, Nicholas M.
    Janssens, Laurens P.
    Hung, Kenneth W.
    Proctor, Deborah
    Ruggiero, Elizabeth
    Kane, Sunanda
    Bruining, David H.
    Faubion, William A.
    Raffals, Laura E.
    Loftus, Edward, V
    Al-Bawardy, Badr
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (08) : 1270 - 1276
  • [50] The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter Study
    Ramos, Guilherme Piovezani
    Dimopoulos, Christina N.
    McDonald, Nicholas M.
    Janssens, Laurens P.
    Hung, Kenneth H.
    Proctor, Deborah
    Ruggiero, Elizabeth
    Bruning, David H.
    Faubion, William
    Raffals, Laura
    Loftus, Edward V., Jr.
    Al-Bawardy, Badr
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S427 - S428
12345